Prognosis
Pfizer-BioNTech Shot Stops Covid Spread, Israeli Study Shows
- Vaccine reported to be 89% effective at preventing infections
- Stopping virus transmission is key to ending Covid-19 pandemic
This article is for subscribers only.
Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.
The Pfizer Inc. and BioNTech SE Covid-19 vaccine appeared to stop the vast majority of recipients in Israel becoming infected, providing the first real-world indication that the immunization will curb transmission of the coronavirus.